Related Experiment Video

Updated: Jul 18, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

Effect of steroids on DNA synthesis in an in vitro replication system: initial quantitative structure-activity

K Azzaoui1, M J Diaz-Perez, M Zannis-Hadjoupoulos

  • 1Department of Oncology, Pharmacokinetics Division, Department of Pharmacology and Therapeutics, and Department of Medicine, McGill University, Montreal, Quebec, Canada.

Journal of Medicinal Chemistry
|May 23, 1998
PubMed

Insights

Steroids impact DNA replication through molecular mechanisms independent of estrogen receptors. Quantitative structure-activity relationships (QSARs) reveal key structural parameters influencing DNA synthesis, aiding in understanding steroid effects on carcinogenesis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Steroids are known to influence cellular processes, including DNA replication, but their precise molecular mechanisms are not fully understood.
  • Estrogen receptors are typically implicated in mediating hormone effects on cellular replication, yet some steroid effects may operate through alternative pathways.
  • Investigating steroid-carcinogenesis links requires understanding their direct impact on DNA synthesis.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which steroids affect DNA replication.
  • To develop a predictive model for steroid bioactivity in DNA synthesis using quantitative structure-activity relationships (QSARs).
  • To explore steroid structure-activity relationships independent of estrogen receptor interactions.

Main Methods:

  • Utilized a HeLa cell-free system to study the effects of various steroids on in vitro DNA replication.
  • Employed quantitative structure-activity relationships (QSARs) to correlate steroid structures with observed bioactivity (DNA synthesis rates).
  • Developed a 3D-QSAR model incorporating pharmacophoric features and global molecular properties to define active and inactive spaces.

Main Results:

  • Steroid effects on DNA replication varied widely, including both enhancement and inhibition.
  • A QSAR equation was derived: %DNA = 23.9(+/-3.8)Xdipact + 57.8(+/-22.4)Hyd - 19.4(+/-10.4)Biophpi + 128.9, linking DNA synthesis to dipole moment, hydrophobicity, and atomic pi population.
  • Molecular conformation, influenced by functional group orientation and dipole moment, was critical for determining activity.

Conclusions:

  • The study identified key structural parameters (dipole moment, hydrophobicity, atomic pi population) that govern steroid-induced alterations in DNA replication.
  • A 3D-QSAR model provides insights into the structural requirements for steroid bioactivity in DNA synthesis, independent of estrogen receptors.
  • These findings contribute to understanding the role of steroids in carcinogenesis and offer a basis for designing novel compounds with targeted effects on DNA replication.

More Related Videos

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 16, 2013

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Concept Videos

Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...